Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

248.91
BATS BZX Real-Time Price
As of 12:08pm ET
 0.00 / 0.00%
Today’s Change
184.50
Today|||52-Week Range
261.27
+18.52%
Year-to-Date
The Good, the Bad and the Ugly (Monday Edition)
Jun 26 / TheStreet.com - Paid Partner Content
The Market Advance Narrows
Jun 22 / TheStreet.com - Paid Partner Content
Halfway Point Points to Biotech, Housing
Jun 26 / TheStreet.com - Paid Partner Content
FDA Commisoner Takes on Big Pharma
Jun 21 / TheStreet.com - Paid Partner Content
Allergan Continues to Focus on Acquisitions and Branded Unit
Jun 26 / Zacks.com - Paid Partner Content
Time Frames and Market Views -- Selling Some Allergan
Jun 20 / TheStreet.com - Paid Partner Content
Dillard's Is One of the Best Long-Term Investments in Retail, Doug Kass Says
Jun 26 / TheStreet.com - Paid Partner Content
5 Reasons Why You Should Invest in AstraZeneca (AZN) in 2017
Jun 20 / Zacks.com - Paid Partner Content
Top Stock Reports for Oracle, Allergan & Abbott
Jun 23 / Zacks.com - Paid Partner Content
Still Lovin' Allergan
Jun 20 / TheStreet.com - Paid Partner Content
My Trading and Investing Activity in Thursday's Session
Jun 23 / TheStreet.com - Paid Partner Content
Global pharma sales forecasts cut amid pricing pressures
Jun 20 / FT.com - Paid Partner Content
The Long and Short of It
Jun 22 / TheStreet.com - Paid Partner Content
AstraZeneca faces up to its year of living dangerously
Jun 11 / FT.com - Paid Partner Content
Getting Ever Smaller in Allergan
Jun 22 / TheStreet.com - Paid Partner Content
Nuns target Google parent over spending on political lobbying
Jun 10 / FT.com - Paid Partner Content
Putting More Allergan Profit in My Pocket
Jun 22 / TheStreet.com - Paid Partner Content
Ohio blames drugmakers for fueling opioid crisis
Jun 01 / CNNMoney.com
Pocketing Some Allergan Profit
Jun 22 / TheStreet.com - Paid Partner Content
Ohio sues drugmakers over US opioid addiction crisis
May 31 / FT.com - Paid Partner Content